Obstructing FDA inspections
Failed to add items
Add to cart failed.
Add to wishlist failed.
Remove from wishlist failed.
Follow podcast failed
Unfollow podcast failed
Obstructing FDA inspections
-
Narrated by:
-
Written by:
About this listen
This episode outlines official FDA guidance regarding the specific behaviors that constitute the obstruction of drug or device inspections. Under federal law, if a facility delays, denies, limits, or refuses an inspection, the products manufactured there are legally considered adulterated. Prohibited actions include failing to schedule pre-announced visits, withholding records, and restricting access to operational areas or photography. While the agency considers legitimate justifications for certain disruptions, such as safety protocols or language barriers, it maintains broad authority to ensure regulatory compliance.
#FDA #RegulatoryCompliance #FDAInspection #Pharma #MedicalDevices #FDALaw #QualityAssurance #AuditReady #LifeSciences #Compliance